We are investigating whether adding Anakinra to standard treatments helps patients with virus-negative myocarditis. This study aims to evaluate its safety and effectiveness compared to usual care.
Health conditions and diseases that the clinical trial is designed to study and treat.
Virus-negative myocarditis is an inflammation of the heart muscle that is not caused by a viral infection. It can lead to symptoms such as chest pain, fatigue, and shortness of breath, affecting the heart's ability to pump blood effectively.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.